Speaker Profile
Ph.D., VP, Data and AI Partnerships, Tempus AI
Biography
Deirdre has spent her career at the forefront of innovation: bringing emerging technologies and platforms to the forefront with the goal of accelerating access to precision medicines.
She oversaw precision medicine initiatives for oncology and non-oncology assets at AstraZeneca and Bristol-Myers Squibb amongst others; launching Companion Diagnostics for Lynparza, Tagrisso, and IO therapeutics in the global markets.
Deirdre launched the global diagnostic strategy for Lynparza, which expanded access and utilization of BRCA testing to optimize patient treatments. She championed liquid biopsy efforts to provide patients and providers with a better understanding of a patient’s disease and treatment options. She led digital diagnostic collaborations at PathAI, building the foundation for the role of AI-Dx in patient diagnosis and treatment. As these technologies became standard of care, and data became interrogatable, Deirdre focused her efforts on the convergence of data and AI to drive innovation.
Deirdre looks forward to a lively discussion today.
Session Abstract – PMWC 2027 Silicon Valley
Track Chair:
Alex Morgan, Khosla Ventures & Gad Getz, Broad Institute
PMWC Award Ceremony
• David Baker, University of Washington (Nobel Laureate, Luminary)
Featured Speakers
• David Baker, University of Washington
• Jack Dent, Chai Discovery
• Dimitri Yatsenko, DataJoint
• Evgeny Kiner, Neosplice Therapeutics
• Alex Morgan, Khosla Ventures
• Gad Getz, Broad Institute
Causal Targets, Not Just Better Molecules
Using AI and human biology to improve target selection before chemistry begins.
Data Is the Moat
What proprietary, longitudinal, and perturbational data really confer advantage.
From Prediction to Patient
Patient stratification, smarter trials, and the handoff from model to clinic.
Designed Biology Meets Drug Development
AI-designed proteins, developability, and what survives contact with reality.
The Target Discovery Bottleneck
Why splicing and other underused biology may expand what is druggable.
PMWC Hall of Impact
Previous Speakers Include
Nobel laureates, technology founders, regulators, CEOs and scientific pioneers who have taken the PMWC stage.
